Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials. (Q46323662)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials. |
scientific article |
Statements
Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials (English)
Sabino Iliceto
Sorin Jakob Brener
Alberto Barioli
Andrea Gratta
Roberta Rossini
Eliano Pio Navarese
Anna Chiara Frigo
Giuseppe Musumeci
Gregg Whitney Stone
19 December 2013